Join us for the BioFinland 05 Investor Forum! April 26–27, 2005, Helsinki, Finland

Participating organisations

BioFinland 05 Investor Forum is a unique two-day conference offering investment opportunities, a wealth of information about new technologies and great networking benefits. Not only will you have the opportunity to listen to the business presentations of the most promising biotech firms in Finland and ScanBalt Area, you will also meet investors as well as executives from some of the global top life science companies.

We have selected top speakers from the global biotech financing and scientific circles to give you an up to the minute insight into the sector, including G. Steven Burrill (Presentation), CEO of Burrill & Company, Nigel Parker, CEO of Ark Therapeutics Group plc, Yann Bonduelle, Head of UK Valuation and strategy, PWC Corporate Financing and Neil D. Cook, Vice President, R&D and CSO of PerkinElmer Corporation.

Investor Forum will feature

Who should attend?

To register as a delegate, please register as an Attendee at our online registration.

To apply as a presenting company, please register as a Presenting Company at our online registration. You will then be contacted by the organizers with further instructions.

Investor Academy—an exclusive pre-Investor Forum workshop for the presenting companies will be organised in Helsinki on April 4-5, 2005. Investor Academy consists of lectures on presentation techniques, backgrounders of participating investors and individual company presentation sparring sessions.

Presenting Companies

Investor Forum will bring to the stage the most influential biotech players in the area and little further. The following companies have been pre-screened by the Advisory Board and will be presenting their business opportunities at the event:

If you wish to network with the best and present your company to the Nordic investor community, apply now by registering as a presenting company.

Investor Forum Advisory Board members